These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 16857792

  • 41. Expression of DCC and netrin-1 in normal human endometrium and its implication in endometrial carcinogenesis.
    Kato HD, Kondoh H, Inoue T, Asanoma K, Matsuda T, Arima T, Kato K, Yoshikawa T, Wake N.
    Gynecol Oncol; 2004 Nov; 95(2):281-9. PubMed ID: 15491747
    [Abstract] [Full Text] [Related]

  • 42. Peroxisome proliferator-activated receptor alpha and gamma ligands differentially affect smooth muscle cell proliferation and migration.
    Zahradka P, Wright B, Fuerst M, Yurkova N, Molnar K, Taylor CG.
    J Pharmacol Exp Ther; 2006 May; 317(2):651-9. PubMed ID: 16407462
    [Abstract] [Full Text] [Related]

  • 43. The PPARgamma ligand, 15-Deoxy-Delta12,14-PGJ2, regulates apoptosis-related protein expression in cholangio cell carcinoma cells.
    Okano H, Shiraki K, Inoue H, Kawakita T, Deguchi M, Sugimoto K, Sakai T, Murata K, Nakano T, Enjoji M.
    Int J Mol Med; 2003 Dec; 12(6):867-70. PubMed ID: 14612959
    [Abstract] [Full Text] [Related]

  • 44. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro.
    Liu JJ, Liu PQ, Lin DJ, Xiao RZ, Huang M, Li XD, He Y, Huang RW.
    Ann Hematol; 2007 Mar; 86(3):173-83. PubMed ID: 17089125
    [Abstract] [Full Text] [Related]

  • 45. Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury.
    Genovese T, Esposito E, Mazzon E, Di Paola R, Muià C, Meli R, Bramanti P, Cuzzocrea S.
    Shock; 2008 Aug; 30(2):142-52. PubMed ID: 18628687
    [Abstract] [Full Text] [Related]

  • 46. Expression of peroxisome proliferator-activated receptor gamma in salivary duct carcinoma: immunohistochemical analysis of 15 cases.
    Mukunyadzi P, Ai L, Portilla D, Barnes EL, Fan CY.
    Mod Pathol; 2003 Dec; 16(12):1218-23. PubMed ID: 14681322
    [Abstract] [Full Text] [Related]

  • 47. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P, Dunlop T, Seifert M, Tilgen W, Reichrath J.
    Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
    [Abstract] [Full Text] [Related]

  • 48. Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines.
    Lecomte J, Flament S, Salamone S, Boisbrun M, Mazerbourg S, Chapleur Y, Grillier-Vuissoz I.
    Breast Cancer Res Treat; 2008 Dec; 112(3):437-51. PubMed ID: 18204896
    [Abstract] [Full Text] [Related]

  • 49. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
    Kim KR, Choi HN, Lee HJ, Baek HA, Park HS, Jang KY, Chung MJ, Moon WS.
    Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342
    [Abstract] [Full Text] [Related]

  • 50. Growth-inhibitory effect of a novel synthetic triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, on ovarian carcinoma cell lines not dependent on peroxisome proliferator-activated receptor-gamma expression.
    Melichar B, Konopleva M, Hu W, Melicharova K, Andreeff M, Freedman RS.
    Gynecol Oncol; 2004 Apr; 93(1):149-54. PubMed ID: 15047229
    [Abstract] [Full Text] [Related]

  • 51. Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines.
    Burton JD, Castillo ME, Goldenberg DM, Blumenthal RD.
    Anticancer Drugs; 2007 Jun; 18(5):525-34. PubMed ID: 17414621
    [Abstract] [Full Text] [Related]

  • 52. IL-6 and PPARgamma signalling in human PC-3 prostate cancer cells.
    Pitulis N, Papageorgiou E, Tenta R, Lembessis P, Koutsilieris M.
    Anticancer Res; 2009 Jun; 29(6):2331-7. PubMed ID: 19528499
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Activation of peroxisome proliferator-activated receptor gamma suppresses telomerase activity in vascular smooth muscle cells.
    Ogawa D, Nomiyama T, Nakamachi T, Heywood EB, Stone JF, Berger JP, Law RE, Bruemmer D.
    Circ Res; 2006 Apr 14; 98(7):e50-9. PubMed ID: 16556873
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. 15-Deoxy-Delta(12,14)-prostaglandin J2 induces IL-8 and GM-CSF in a human airway epithelial cell line (NCI-H292).
    Chiba T, Ueki S, Ito W, Kato H, Takeda M, Kayaba H, Furue M, Chihara J.
    Int Arch Allergy Immunol; 2009 Apr 14; 149 Suppl 1():77-82. PubMed ID: 19494510
    [Abstract] [Full Text] [Related]

  • 58. PPARgamma ligands suppress proliferation of human urothelial basal cells in vitro.
    Kawakami S, Arai G, Hayashi T, Fujii Y, Xia G, Kageyama Y, Kihara K.
    J Cell Physiol; 2002 Jun 14; 191(3):310-9. PubMed ID: 12012326
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.